Application 207486

Type
ANDA
Sponsor
WEST-WARD PHARMS INT

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EVEROLIMUSEVEROLIMUSTABLET;ORAL2.5MGNoNo
002EVEROLIMUSEVEROLIMUSTABLET;ORAL5MGNoNo
003EVEROLIMUSEVEROLIMUSTABLET;ORAL7.5MGNoNo
004EVEROLIMUSEVEROLIMUSTABLET;ORAL10MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0054-0480EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0480EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0480EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0480EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0480EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0480EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0481EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0481EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0481EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0481EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0481EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0481EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0482EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0482EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0482EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0497EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0497EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0497EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0497EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0497EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent
0054-0497EverolimusEverolimusHikma Pharmaceuticals USA Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
59593ORIG2019-08-06